Terms: = Liver cancer AND BTG1, P62324, 694, ENSG00000133639 AND Treatment
34 results:
1. Embedding expertise knowledge into inverse treatment planning for low-dose-rate brachytherapy of hepatic malignancies.
Zhu J; Wang C; Teng S; Lu J; Lyu P; Zhang P; Xu J; Lu L; Teng GJ
Med Phys; 2024 Jan; 51(1):348-362. PubMed ID: 37475484
[TBL] [Abstract] [Full Text] [Related]
2. Immunotherapy with Autoimmune Complication in Renal cancer.
Sunil SP; Kumar S; Hussaini S; Kandula S
J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116021
[TBL] [Abstract] [Full Text] [Related]
3. Vincristine and dexamethasone pulses in addition to maintenance therapy among pediatric acute lymphoblastic leukemia (GD-ALL-2008): An open-label, multicentre, randomized, phase III clinical trial.
Qiu KY; Wang JY; Huang LB; Li CG; Xu LH; Liu RY; Chen HQ; Ruan YS; Zhen ZJ; Li CK; Fang JP
Am J Hematol; 2023 Jun; 98(6):869-880. PubMed ID: 36877527
[TBL] [Abstract] [Full Text] [Related]
4. Hepatic decompensation after transarterial radioembolization: A retrospective analysis of risk factors and outcome in patients with hepatocellular carcinoma.
Reincke M; Schultheiss M; Doppler M; Verloh N; Uller W; Sturm L; Thimme R; Goetz C; Bettinger D
Hepatol Commun; 2022 Nov; 6(11):3223-3233. PubMed ID: 36064940
[TBL] [Abstract] [Full Text] [Related]
5. liver Transplant Recipients Who Survive for More Than 10 Years: A Long-Term Survey.
Ayvazoğlu Soy EH; Akdur A; Karakaya E; Moray G; Haberal M
Exp Clin Transplant; 2022 Mar; 20(Suppl 1):20-23. PubMed ID: 35384803
[TBL] [Abstract] [Full Text] [Related]
6. Refractory Hyperammonemic encephalopathy in Fibrolamellar hepatocellular carcinoma, a case report and literature review.
Ahmed A; Ata F; Gaber M; Petkar M; Mahfouz A; Schirmacher P; Musa S; Hashim A
Curr Probl Cancer; 2022 Jun; 46(3):100847. PubMed ID: 35276469
[TBL] [Abstract] [Full Text] [Related]
7. [Effects of tumor protein translation control antisense RNA1 on radiosensitivity, proliferation, migration and invasion of hepatocellular carcinoma cells by targeting miR-30c-5p].
Zhai JJ; Du XR; Li CX
Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):1054-1061. PubMed ID: 34695895
[No Abstract] [Full Text] [Related]
8. treatment response, survival and safety profile of transarterial chemoembolization using different sizes of drug-eluting beads in hepatocellular carcinoma patients with portal vein tumor thrombus.
Lyu T; Yao H; Wang J; Song L; Tong X; Zou Y
Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101819. PubMed ID: 34619365
[TBL] [Abstract] [Full Text] [Related]
9. Benign Biliary Stricture after Yttrium-90 Radioembolization for Hepatocellular Carcinoma.
Kim HC; Joo I; Lee M; Chung JW
J Vasc Interv Radiol; 2020 Dec; 31(12):2014-2021. PubMed ID: 33168372
[TBL] [Abstract] [Full Text] [Related]
10. treatment of chronic hepatitis C regiments containing with recombinant interferon in patients with sustained virological response predicts risk of hepatocellular carcinoma: A meta-analysis.
Li CF; Tsao SM; Liao HH; Chen SC; Lee YT
Medicine (Baltimore); 2020 Oct; 99(40):e22435. PubMed ID: 33019424
[TBL] [Abstract] [Full Text] [Related]
11. The combination therapy of transarterial chemoembolisation and sorafenib is the preferred palliative treatment for advanced hepatocellular carcinoma patients: a meta-analysis.
Cheng Z; He L; Guo Y; Song Y; Song S; Zhang L
World J Surg Oncol; 2020 Sep; 18(1):243. PubMed ID: 32917226
[TBL] [Abstract] [Full Text] [Related]
12. Dynamic Contrast-Enhanced Magnetic Resonance Imaging as Imaging Biomarker for Vascular Normalization Effect of Infigratinib in High-FGFR-Expressing Hepatocellular Carcinoma Xenografts.
Tran A; Koh TS; Prawira A; Ho RZW; Le TBU; Vu TC; Hartano S; Teo XQ; Chen WC; Lee P; Thng CH; Huynh H
Mol Imaging Biol; 2021 Feb; 23(1):70-83. PubMed ID: 32909245
[TBL] [Abstract] [Full Text] [Related]
13. Imaging Predictors of Survival in Patients with Single Small Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
Park C; Kim JH; Kim PH; Kim SY; Gwon DI; Chu HH; Park M; Hur J; Kim JY; Kim DJ
Korean J Radiol; 2021 Feb; 22(2):213-224. PubMed ID: 32901464
[TBL] [Abstract] [Full Text] [Related]
14. Comparative analysis between interstitial brachytherapy and stereotactic body irradiation for local ablation in liver malignancies.
Hass P; Mohnike K; Kropf S; Brunner TB; Walke M; Albers D; Petersen C; Damm R; Walter F; Ricke J; Powerski M; Corradini S
Brachytherapy; 2019; 18(6):823-828. PubMed ID: 31522972
[TBL] [Abstract] [Full Text] [Related]
15. Abnormal expression and mechanism of miR-330-3p/btg1 axis in hepatocellular carcinoma.
Zhao X; Chen GQ; Cao GM
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6888-6898. PubMed ID: 31486488
[TBL] [Abstract] [Full Text] [Related]
16. A new ALBI-based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma.
Lee IC; Hung YW; Liu CA; Lee RC; Su CW; Huo TI; Li CP; Chao Y; Lin HC; Hou MC; Huang YH
Liver Int; 2019 Sep; 39(9):1704-1712. PubMed ID: 31319016
[TBL] [Abstract] [Full Text] [Related]
17. Noninvasive inflammatory markers for assessing liver fibrosis stage in autoimmune hepatitis patients.
Yuan X; Duan SZ; Cao J; Gao N; Xu J; Zhang L
Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1467-1474. PubMed ID: 31107735
[TBL] [Abstract] [Full Text] [Related]
18. [Clinical Predictive Factors associated with First Line EGFR-TKI Efficacy
in Advanced NSCLC Patients with EGFR Mutations].
Chen M; Xu Y; Zhao J; Zhong W; Wang M
Zhongguo Fei Ai Za Zhi; 2019 Feb; 22(2):99-104. PubMed ID: 30827326
[TBL] [Abstract] [Full Text] [Related]
19. Efficacy of
Li S; He X; Dang L; Xu F; Fang J; Li F; Wang W
Dig Dis Sci; 2018 Feb; 63(2):321-328. PubMed ID: 29305738
[TBL] [Abstract] [Full Text] [Related]
20. An inflammation-based prognostic score, the C-reactive protein/albumin ratio predicts the morbidity and mortality of patients on parenteral nutrition.
Llop-Talaveron J; Badia-Tahull MB; Leiva-Badosa E
Clin Nutr; 2018 Oct; 37(5):1575-1583. PubMed ID: 28912009
[TBL] [Abstract] [Full Text] [Related]
[Next]
